News
News releases on December 7, 2025
Every news release public companies put out on December 7, 2025 (UTC): 88 news releases, newest first. Open any release to read it.
AMP launches Constructor Series in partnership with Dimensional and SouthPeak
AMP Limited · Dec 7, 2025
Immix Biopharma Announces Pricing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Immix Biopharma, Inc. · Dec 7, 2025
At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially...
Immix Biopharma, Inc. · Dec 7, 2025
QBE Insurance: At QBE, we aim to use our role as a global insurer to help progress the transition to a net zero economy by supporting our...
QBE Insurance Group Limited · Dec 7, 2025
Qantas Airways: BRINGS INTERNATIONAL FLYING BACK TO THE GOLD COAST
Qantas Airways Limited · Dec 7, 2025
GDM: Settlement of ADG Dispute and Acquisition of Challenger
Amara Minerals Limited · Dec 7, 2025
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
BeOne Medicines Ltd. · Dec 7, 2025
SELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025
SELLAS Life Sciences Group, Inc. · Dec 7, 2025
Qantas Airways: SET TO WELCOME HOLIDAY TRAVELLERS TO NEW AUCKLAND INTERNATIONAL LOUNGE
Qantas Airways Limited · Dec 7, 2025
National Fuel Gas Company Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights - NFG
New Found Gold Corp · Dec 7, 2025
Shareholder Lock-In: Shares worth ₹6,523 crore of eight companies to free up for trade this week
Billionbrains Garage Ventures Limited · Dec 7, 2025
Drilling hits wide zone of mineralisation in new area well outside resource
Cygnus Metals Limited · Dec 7, 2025
Gartner Announces Gartner Finance Symposium/Xpo 2026 in Sydney
Gartner, Inc. · Dec 7, 2025
Lynozyfic™ (linvoseltamab) Monotherapy in Newly Diagnosed Multiple Myeloma (NDMM) Shows Impressive Responses, Supporting Rationale as a P...
Regeneron Pharmaceuticals, Inc. · Dec 7, 2025
Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patient...
Lyell Immunopharma, Inc. · Dec 7, 2025
Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)
Eli Lilly and Company · Dec 7, 2025
Press Release Dec 07 2025
Ola Electric Mobility Limited · Dec 7, 2025
Reliance Infrastructure: Investor Presentation
Reliance Infrastructure Limited · Dec 7, 2025
Prologis announces redemption of 3.00% Notes due 2026
Prologis, Inc. · Dec 7, 2025
Fletcher Building: Update on Funding Facilities
Fletcher Building Limited · Dec 7, 2025
Sub Division of Shares
York Arcade Holdings PLC · Dec 7, 2025
Errata to the Annual Report for the year ended 31st March 2025
Odel PLC · Dec 7, 2025
Annual General Meeting 2025
Odel PLC · Dec 7, 2025
COXA: Revenue surged 104% YoY to $7,742.2M, with net income up 30.5% to $566.7M
Cox Energy America SAB de CV · Dec 7, 2025
Press Release Dec 07 2025
Delhivery Limited · Dec 7, 2025
Standard Shoe Sole & Mould India Ltd. Press Release Dec 07 2025
Standard Shoe Sole & Mould India Ltd. · Dec 7, 2025
Notice Of 49Th Annual General Meeting Of The Company For The FY 2024-25
Standard Shoe Sole & Mould India Ltd. · Dec 7, 2025
ORTELIUS strengthens the balance sheet by offsetting the receivable in a new share issue
Ortelius International AB (publ) · Dec 7, 2025
ORTELIUS Secures SEK 5 Million Financing to Support Continued Development
Ortelius International AB (publ) · Dec 7, 2025
Air Transat (TSX: TRZ) - A deplorable situation demonstrating the Board of Directors' inability to ensure the company's long-term viability.
Transat A.T. Inc. · Dec 7, 2025
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec...
CSL Limited · Dec 7, 2025
IBC Advanced Alloys Reports Results from its 2025 Annual General Meeting
IBC Advanced Alloys Corp. · Dec 7, 2025
Blue Cloud Softech Solutions Ltd. Press Release Dec 07 2025
Blue Cloud Softech Solutions Ltd. · Dec 7, 2025
Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meetin...
Rigel Pharmaceuticals, Inc. · Dec 7, 2025
Nayax Considering an Offering of Notes and Warrants in Israel
Nayax Ltd. · Dec 7, 2025
Pilot union strike notice: Air Transat will have to implement gradual and orderly shutdown plan
Transat A.T. Inc. · Dec 7, 2025
Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatou...
Prime Drink Group Corp · Dec 7, 2025
Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatou...
Prime Medicine, Inc. · Dec 7, 2025
ALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Stand...
ALX Oncology Holdings Inc. · Dec 7, 2025
Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination...
Genmab A/S · Dec 7, 2025
PRESSR: Jazeera Airways recognizes long-standing partners to mark 20 years of flying
Jazeera Airways Co. (KSC) · Dec 7, 2025
Eternal shares swing between gains and losses after ₹1,535 crore block deal
Eternal Limited · Dec 7, 2025
Polyspin Exports Limited Press Release Dec 07 2025
Polyspin Exports Limited · Dec 7, 2025
Afcom Holdings Limited Press Release Dec 07 2025
Afcom Holdings Limited · Dec 7, 2025
PRESSR: Boursa Kuwait enters a strategic partnership with INJAZ to empower Kuwaiti youth and promote financial literacy
Boursa Kuwait Securities Company (K.P.S.C) · Dec 7, 2025
Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting
Molecular Partners AG · Dec 7, 2025
ASH 2025 | Ascentage Pharma Presents Encouraging Data from Phase Ib/II Study of Bcl-2 Inhibitor Lisaftoclax in Venetoclax–Exposed Patient...
Ascentage Pharma Group International · Dec 7, 2025
Linux Foundation Welcomes Mitsubishi Electric as Gold Member During Open Source Summit Japan
Mitsubishi Electric Corp. · Dec 7, 2025
CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies
Clinuvel Pharmaceuticals Limited · Dec 7, 2025
Bonus, Stock Split, Rights Issue Alert: These companies see record dates this upcoming week
V L S Finance Limited · Dec 7, 2025
Bonus, Stock Split, Rights Issue Alert: These companies see record dates this upcoming week
Bharat Rasayan Limited · Dec 7, 2025
Ooredoo Q P S C: Signs Sponsorship Agreement with Apex Health for Upcoming Doha Marathon by 2026
Ooredoo Q.P.S.C · Dec 7, 2025
CARsgen's CAR-T Product Zevor-Cel Included in China's Commercial Health Insurance Innovative Drug Catalogue
CARsgen Therapeutics Holdings Ltd. · Dec 7, 2025
PROJECTS: Miahona-led consortium selected as preferred bidder for $799mln Arana ISTP project
Miahona Co. · Dec 7, 2025
Announcement under Regulation 30 (LODR)-Change in Management
Standard Shoe Sole & Mould India Ltd. · Dec 7, 2025
Announcement under Regulation 30 (LODR)-Change in Management
Standard Shoe Sole & Mould India Ltd. · Dec 7, 2025
Tech-Bank Food's November Hog Sales Revenue At 654 Million Yuan
Tech-bank Food Co., Ltd. · Dec 7, 2025
Guanglian Aviation Industry's Chairman Released From Detention
Guanglian Aviation Industry Co., Ltd. · Dec 7, 2025
Rnit Ai Solutions Limited Press Release Dec 07 2025
RNIT AI Solutions Limited · Dec 7, 2025
Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
Onco-Innovations Ltd. · Dec 7, 2025
Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
Cboe Global Markets, Inc. · Dec 7, 2025
Trading In Xiamen Anne's Shares To Resume On December 8
Xiamen Anne Corporation Limited · Dec 7, 2025
Trading In Shanghai Guao Electronic Technology's Shares To Halt
Shanghai Guao Electronic Technology Co., Ltd. · Dec 7, 2025
Kuang-Chi Technologies's Unit Signs Contracts For Metamaterial Product Deliveries
Kuang-Chi Technologies Co., Ltd. · Dec 7, 2025
Trading In Jiangsu Skyray Instrument's Shares To Resume
Jiangsu Skyray Instrument Co., Ltd. · Dec 7, 2025
Fermenta Biotech Ltd Press Release Dec 07 2025
Fermenta Biotech Ltd · Dec 7, 2025
All Approved Indications of Five Akeso's Innovative Drugs Included in China's Latest NRDL: Featuring Two First-in-Class Bispecifics with ...
Akeso, Inc. · Dec 7, 2025
Mayar Holding Says Newplast Co's MoU With Avant Sports Terminated
Mayar Holding Co. · Dec 7, 2025
Qantas Airways: EXPANDS PERTH HUB WITH NEW DIRECT JOHANNESBURG AND AUCKLAND ROUTES
Qantas Airways Limited · Dec 7, 2025
Marafiq Selected As Preferred Bidder For Arana ISTP Project
Power and Water Utility Company for Jubail and Yanbu (Marafiq) · Dec 7, 2025
Amwaj International Detects Financial Violations In Branch
Amwaj International Co · Dec 7, 2025
Waja Co Applies To Move To Main Market
WAJA company · Dec 7, 2025
Al Hammadi Says Sudair Pharma Applies For IPO On Main Market
Al Hammadi Holding · Dec 7, 2025
Marg Techno Projects Ltd. Press Release Dec 07 2025
Marg Techno Projects Ltd. · Dec 7, 2025
Luberef Gets Notice From Aramco on Successor Feedstock Supply Agreement For Jeddah Facility
Saudi Aramco Base Oil Company - Luberef · Dec 7, 2025
Zai Lab Announces Updates to China’s National Reimbursement Drug List
Zai Lab Ltd. · Dec 7, 2025
Yescarta® Delivers Consistent Safety, Efficacy, and Quality of Life Benefits Across Broad Range of Relapsed/Refractory Large B-cell Lymph...
Gilead Sciences, Inc. · Dec 7, 2025
Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
Wave Life Sciences Ltd. · Dec 7, 2025
Matthews International Provides Update on Actions to Create Shareholder Value and Addresses Director Nominations
Matthews International Corporation · Dec 7, 2025
Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA
Incyte Corporation · Dec 7, 2025
Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosi...
Incyte Corporation · Dec 7, 2025
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: The FX Super One First Pre-Production Vehicles Roll-off Ceremony ...
Faraday Future Intelligent Electric Inc. · Dec 7, 2025
Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DE...
Dyne Therapeutics, Inc. · Dec 7, 2025
Dsm Fresh Foods Limited Press Release Dec 07 2025
DSM Fresh Foods Limited · Dec 7, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
DSM Fresh Foods Limited · Dec 7, 2025
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
Nuvation Bio Inc. · Dec 7, 2025
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
Innovent Biologics, Inc. · Dec 7, 2025
University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,0...
Abbott Laboratories · Dec 7, 2025